A McCleery1, J Ventura2, R S Kern3, K L Subotnik2, D Gretchen-Doorly2, M F Green3, G S Hellemann2, K H Nuechterlein4. 1. Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States. Electronic address: amccleery@mednet.ucla.edu. 2. Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States. 3. Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States; VISN 22 Mental Illness Research, Education, and Clinical Center (MIRECC), Greater Los Angeles VA Healthcare System, Los Angeles, CA, United States. 4. Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States; Department of Psychology, UCLA, Los Angeles, CA, United States.
Abstract
BACKGROUND: Although many studies have assessed cognitive functioning in first-episode schizophrenia (FESz), the pattern and severity of impairment across cognitive domains remain unclear. Moreover, few studies have directly compared the pattern of cognitive performance between FESz and chronic schizophrenia (CSz). In this study we examined the cognitive impairment profile in FESz using a standardized neurocognitive battery (MATRICS Consensus Cognitive Battery; MCCB). METHODS: MCCB data were compared from 105 FESz patients, 176 CSz patients and 300 non-psychiatric (NP) participants. Mixed model analysis evaluated group differences in MCCB profiles and relative strengths and weaknesses in the MCCB profiles of patients. Clinical implications of MCCB performance were also examined; we compared the proportion of participants from each group who exhibited clinically-significant global cognitive impairment based on the MCCB Overall Composite score. RESULTS: FESz and CSz showed impaired performance across all MCCB domains relative to NP. With the exception of relative preservation of working memory and social cognition in FESz, the MCCB domain scores were similar in FESz and CSz. The distribution of impairment on the Overall Composite score did not significantly differ between FESz and CSz; compared to NP, both patient groups were overrepresented in moderate and severe impairment categories. CONCLUSION: The pattern, magnitude, and distribution of severity of impairment in FESz were similar to that observed in CSz. However, early in the illness, there may be relative sparing of working memory and social cognition.
BACKGROUND: Although many studies have assessed cognitive functioning in first-episode schizophrenia (FESz), the pattern and severity of impairment across cognitive domains remain unclear. Moreover, few studies have directly compared the pattern of cognitive performance between FESz and chronic schizophrenia (CSz). In this study we examined the cognitive impairment profile in FESz using a standardized neurocognitive battery (MATRICS Consensus Cognitive Battery; MCCB). METHODS: MCCB data were compared from 105 FESz patients, 176 CSzpatients and 300 non-psychiatric (NP) participants. Mixed model analysis evaluated group differences in MCCB profiles and relative strengths and weaknesses in the MCCB profiles of patients. Clinical implications of MCCB performance were also examined; we compared the proportion of participants from each group who exhibited clinically-significant global cognitive impairment based on the MCCB Overall Composite score. RESULTS: FESz and CSz showed impaired performance across all MCCB domains relative to NP. With the exception of relative preservation of working memory and social cognition in FESz, the MCCB domain scores were similar in FESz and CSz. The distribution of impairment on the Overall Composite score did not significantly differ between FESz and CSz; compared to NP, both patient groups were overrepresented in moderate and severe impairment categories. CONCLUSION: The pattern, magnitude, and distribution of severity of impairment in FESz were similar to that observed in CSz. However, early in the illness, there may be relative sparing of working memory and social cognition.
Authors: Anna Comparelli; Antonella De Carolis; Valentina Corigliano; Silvia Romano; Giorgio D Kotzalidis; Chiara Campana; Stefano Ferracuti; Roberto Tatarelli; Paolo Girardi Journal: J Nerv Ment Dis Date: 2011-10 Impact factor: 2.254
Authors: Robert S Kern; Keith H Nuechterlein; Michael F Green; Lyle E Baade; Wayne S Fenton; James M Gold; Richard S E Keefe; Raquelle Mesholam-Gately; Jim Mintz; Larry J Seidman; Ellen Stover; Stephen R Marder Journal: Am J Psychiatry Date: 2008-01-02 Impact factor: 18.112
Authors: K H Nuechterlein; M E Dawson; M Gitlin; J Ventura; M J Goldstein; K S Snyder; C M Yee; J Mintz Journal: Schizophr Bull Date: 1992 Impact factor: 9.306
Authors: Helene E Barder; Kjetil Sundet; Bjørn R Rund; Julie Evensen; Ulrik Haahr; Wenche Ten Velden Hegelstad; Inge Joa; Jan O Johannessen; Johannes Langeveld; Tor K Larsen; Ingrid Melle; Stein Opjordsmoen; Jan I Røssberg; Erik Simonsen; Per Vaglum; Thomas McGlashan; Svein Friis Journal: Front Hum Neurosci Date: 2013-10-07 Impact factor: 3.169
Authors: Katarzyna Rek-Owodziń; Ernest Tyburski; Piotr Plichta; Katarzyna Waszczuk; Maksymilian Bielecki; Krzysztof Wietrzyński; Piotr Podwalski; Krzysztof Rudkowski; Anna Michalczyk; Tomasz Grąźlewski; Leszek Sagan; Jolanta Kucharska-Mazur; Jerzy Samochowiec; Monika Mak Journal: J Clin Med Date: 2022-05-06 Impact factor: 4.964
Authors: Jana Drgonova; Donna Walther; Sulabh Singhal; Kennedy Johnson; Brice Kessler; Juan Troncoso; George R Uhl Journal: PLoS One Date: 2015-07-14 Impact factor: 3.240